Combination of Fimasartan/Amlodipine/Rosuvastatin in Patients With Essential Hypertension and Dyslipidemia
Status:
Completed
Trial end date:
2018-12-07
Target enrollment:
Participant gender:
Summary
The objective of this clinical study is to evaluate the efficacy and safety by comparing the
fimasartan/amlodipine/rosuvastatin treatment group to the fimasartan/amlodipine treatment
group and the fimasartan/rosuvastatin treatment group respectively at Week 8 in patients with
essential hypertension and dyslipidemia who fail to respond to the fimasartan monotherapy.